A61L31/028

Multi-layer biodegradable device having adjustable drug release profile

Methods and apparatus for a biodegradable multi-layer device suitable for medical applications are provided, wherein the device is formed from multiple film-layers configured to have different characteristics from one another such as different release profiles for therapeutic agents, adhesive properties, stiffness properties, and solubility properties. The film-layers may include a solid fibrinogen component. A device having multiple film-layers may take a non-adherent form during delivery to a target location within or on tissue, and thereafter may be exposed to moisture to take an adherent form on the tissue. The device may include a number of additives, including materials to improve the mechanical properties of the device, or one or more therapeutic or contrast agents.

STENTS HAVING A HYBRID PATTERN AND METHODS OF MANUFACTURE
20170151074 · 2017-06-01 ·

An intravascular stent and method of making an intervascular stent having a hybrid pattern a. The hybrid pattern comprises a plurality of circumferentially self-expansible members comprising a plurality of interconnected, geometrically deformable closed cells, adjacent self-expansible members interconnected by a plurality of bridge members linking a first interconnection between two closed cells in a first self-expansible member to a second interconnection between two closed cells in a second self-expansible member, wherein the second interconnection is circumferentially offset and non-adjacent to the first interconnection.

Sinterable and/or fusible ceramic mass, production and use thereof

A sinterable and/or fusible ceramic mass is disclosed, having a long-term stable compound of crystalline phases of apatite, wollastonite, titanite and optionally cristobalite, which is stabilized by a glass phase, and a production process therefor. The ceramic mass can be obtained by sintering a mixture comprising at least the constituents SiO.sub.2, CaO, P.sub.2O.sub.5, MgO, CaF.sub.2 and TiO.sub.2, on their own or in combination with at least one alkali oxide, the alkali oxide being chosen from NaO.sub.2 and K.sub.2O. The invention further relates to uses of the sintered material in the form of shaped articles for strengthening, cleaning, roughening or polishing surfaces of medical implants or as a final prosthesis.

MEDICAL DRAPES AND METHODS FOR REDUCING TRAUMA ON REMOVAL
20170135862 · 2017-05-18 ·

In some illustrative examples, a medical drape suitable for treating a tissue site may include an adherent surface including first adherent force profile oriented along a first axis and a second adherent force profile oriented along a second axis. The first adherent force profile may have an average force less than an average force of the second adherent force profile. Other apparatuses, systems, and methods are also provided.

DEVICES FOR EFFECTING FASTER HEALING OF ORTHOPEDIC AND OTHER WOUNDS

Disclosed are medical devices, e.g., surgical sutures, surgical staples, surgical pads, surgical meshes, surgical scaffolds etc., and methods of use at a wound in a patient to facilitate the rapid healing of the tissue at the situs of the wound with minimal fibrous tissue formation. The devices are arranged to be brought into engagement with tissue adjacent the wound to close the wound and include a core formed of a piezo-electric material and an outer layer covering the core. The outer layer is platelet derived growth factors. The methods of use of the devices also include applying a local molecular energy production agent to the wound and irradiating the wound with a pulsed infra-red laser beam.

Bioresorbable Silicon Electronics for Transient Implants
20170128015 · 2017-05-11 ·

Provided are implantable and bioresorbable medical devices comprising a bioresorbable substrate and an electronic circuit supported by the bioresorbable substrate. The electronic circuit comprises a membrane of silicon having a thickness less than or equal to 5 m and an array of dissolvable electrodes, wherein the dissolvable electrodes are formed from the membrane of silicon. The electronic circuit is configured to conformally contact a biological tissue and electrically interface with biological tissue during use. The silicon may be highly doped to provide the requisite characteristics for electrically interfacing with biological tissue, and may be further used to form other components of the electronic circuit, including back-plane transistors electrically connected to the electrode array.

Platelet-activated bioadhesive stent coating as an antimigration mechanism
09642944 · 2017-05-09 · ·

A stent having an inner surface and an outer surface, the stent comprising a coating composition comprising a platelet-activated adhesive on at least a portion of the outer surface thereof.

BIODEGRADABLE METAL STENT AND METHOD OF MAKING
20170095358 · 2017-04-06 ·

The invention is related to a biodegradable stent for vascular placement comprising, a tubular biodegradable metal structure, a biodegradable organic layer covering the surfaces of the structure, and optionally a biodegradable polymer coating covering the organic surface layer. The organic layer is a derivative of a monomer vapor injected plasma and is applied in a plasma enhanced chemical vapor deposition process. Thereby the biodegradable organic layer is an organosilane layer and the biodegradable polymer coating contains a therapeutic drug.

Radioactive Monolayer Surface Coating
20170087279 · 2017-03-30 ·

Disclosed are compositions including a film enriched with a radioisotope relative to its natural abundance, wherein the film has a thickness of one to ten atomic or molecular layers, decay of the radioisotope comprises emission of electrons, and a majority of the emitted electrons have an energy less than or equal to 700 electron volts (ev). Also disclosed are methods for making the compositions. The compositions can be used in microarrays, nanoarrays, microparticles, nanoparticles, power sources, sensing devices, and medical devices; they may also be used in a method of delivering low-energy electrons to a liquid, solid, molecular layer, or cell.

A PROCESS OF MANUFACTURING DIPPED LATEX PRODUCTS WITHOUT USING ANIMAL DERIVATIVES AND PRODUCTS THEREOF
20170081484 · 2017-03-23 ·

The present disclosure provides for a process for manufacturing of dipped latex products without using any animal derived ingredients and dipped latex products produced by said process. The disclosed process successfully over comes drawbacks of drop in product yield (due to coagulum formation) and burst pressures caused by absence-of casein in latex formulation. Therefore, the dipped latex products so produced through the process have final composition similar to that of any other dipped latex products with casein except for absence of casein and having 0.8 phr of Sulphur as against 0.6 phr of Sulphur in routine manufacturing. The products also exhibit physical properties similar to that of any other dipped latex products with casein, such as burst pressure and burst volume.